An Intra-Articular, Extended-Release Formulation of Triamcinolone Acetonide Prolongs and Amplifies Analgesic Effect in Patients with Osteoarthritis of the Knee: A Randomized Clinical Trial
Conclusions:
Intra-articular injection of FX006, an extended-release formulation of triamcinolone acetonide, provided a clinically relevant improvement in pain relief in patients with knee osteoarthritis relative to immediate-release triamcinolone acetonide, the current standard of care.
Level of Evidence:
Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
Source: The Journal of Bone and Joint Surgery - Category: Orthopaedics Authors: Bodick, N., Lufkin, J., Willwerth, C., Kumar, A., Bolognese, J., Schoonmaker, C., Ballal, R., Hunter, D., Clayman, M. Tags: Knee Scientific Articles Source Type: research
More News: Clinical Trials | Corticosteroid Therapy | Orthopaedics | Osteoarthritis | Pain | Study | Triamcinolone | Universities